Cardiome Announces CEO Doug Janzen Has Left Company
Cardiome Pharma Corp. (NASDAQ: CRME) today announced that CEO Doug Janzen has left the Company. Dr. William Hunter, a member of the Company's board of directors, has been appointed interim CEO.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.